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Food and Agricultural Research: 
Innovation to Transform Human Health
• The role that food plays in human health is historic and broad. "Let your food be your 
remedy,” attributed to Hippocrates 24 centuries ago, and "an apple a day keeps the doc­
tor away” both encapsulate the food-health relationship.
• A 21st-century plan to make food and agriculture a full partner in human health is pro­
posed. It builds on multiple seminal contributions to key treatment advances from re­
search in food and agriculture, and expands low-cost approaches and quality-of-life ben­
efits by mitigating diet-related diseases.
• A 10% reduction in healthcare costs would save over $200 billion every year.
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he National Agricultural Biotechnology Council (NABC), a consortium of
over thirty major research and educational institutions in the United States 
and Canada, has developed Food and Agricultural Research: Innovation to 
Transform Human Health. This document proposes a 21st-century plan to make 
food and agriculture a full partner in improved human health. The proposal builds 
on multiple seminal contributions to key treatment advances from research in 
food and agriculture, including veterinary medicine and nutrition, and expands 
low economic-cost and quality-of-life benefits through mitigation of diet-related
We are excited by this opportunity for food and agricultural research to expand its 
contributions to our human-health challenge. The track record and potential are 
succinctly stated and a plan of action outlined. A 10% reduction in healthcare costs 
would be equivalent to over $200 billion annually.
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Food and Agricultural Research:
Innovation to Transform Human Health
Executive Summary
Delivery of healthcare is one of the most pressing social, economic, technical and political challenges of our time. Of the expenditure on healthcare in the United States—$2.2 P illion, 16% of the gross 
domestic product in 2007, and growing at more than twice the rate of inflation—diet-related chronic 
diseases, diabetes, heart disease, stroke, cancer, obesity and asthma, etc., account for about 75%. Emphasis 
has been on therapeutic and surgical treatments after disease development; prevention through food and 
diet has been under-utilized.
Research in food and agriculture has the potential to aid development of relatively low-cost, preventive 
solutions to these pressing healthcare issues. This Food and Agricultural Research: Innovation to 
Transform Human Health report provides justification and an action plan.
Research in food and agriculture, including nutrition and veterinary medicine, has an impressive record. 
Multiple seminal, innovative and transforming contributions have been made to the discovery, description, 
prevention and treatment of human disease including:
• Vaccines • Models • Prion Diseases
• Antibiotics • Production Systems • Small RNA Therapeutics
• Biosourced Therapeutics • HIV • Biopharma Therapeutics
Developments in biology, including molecular genetics, will provide the knowledge, tools, and 
opportunities to couple food and agriculture with new approaches to improving human health and 
containing costs.. These mainly preventive approaches include:
• Essential Nutrient • Toxin/Allergen Reduction • Nutrigenomics
• Functional Foods • Altering Diet • Food Safety
• Probiotics • Enhanced Flavor/Taste • Education/Communication
To expeditiously bring these benefits to human healthcare, we need a structure that integrates food and 
agricultural research as a full partner in the national health-research mission. Current national funding for 
research on food and agriculture must be expanded substantially to ensure timely delivery of preventive 
benefits. This investment is justifiable in terms of the cost savings that will result from disease prevention. 
A 10% cost reduction would save over $200 billion every year.
The new funding should be competitive and open to individuals and, in particular, to self-assembled 
groups possessing necessary skills, e.g. scientists, sociologists, economists, communicators/educators, 
marketers and regulators, from academe, government and industry. Examples of such structures exist. 
Each program will target specific objectives to improve health.
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Introduction12
Preservation of human health is one of the most pressing social, economic, technical and political challenges of 
our time .$2.2 tri llion—16% ofthe gross domestic product— 
were spent on US human healthcare in 2007. These costs 
are growing at an unsustainable rate of over twice that 
of inflation in the United States and Canada. Diet-related 
chronic diseases such as diabetes, heart disease, stroke, 
cancer, obesity and asthma account for about 75% of US 
expenditure3. Food and agricultural research must become 
full partners to provide the necessary knowledgebase and 
technology to aid development of proactive solutions 
to healthcare issues that are primarily preventive and 
relatively low cost rather than reactive therapeutic and 
surgical solutions that are costly in economic and quality- 
of-life terms.
Food and Agricultural Research: Innovation to 
Transform Human Health justifies greatly expanded 
investment in this area.
Food will continue to provide nutrition, but will also 
have a prominent role in the prevention of disease. This 
role for food and agricultural research is potentially huge, 
but is poorly recognized and underfunded. The objective 
of this white paper is to expand awareness and stimulate 
action so that human health will fully benefit from the 
projected major contributions from food and agriculture. 
The explosion in life-science knowledge and technology 
are creating novel opportunities for timely delivery of these 
benefits.
Major Seminal Contributions 
and Future Potential4
Research in food and agriculture, including nutrition and veterinary medicine, has an impressive record 
with many seminal contributions to the discovery, 
description, prevention and treatment of disease. Examples 
of transformative, innovative contributions, and future 
potentials, include:
1 The National Agricultural Biotechnology Council has already pro­
duced reports relating to food, agriculture and human health. Most rel­
evant is NABC Report 14, Integrating Agriculture, Medicine and Food 
for Future Health (2002); others are NABC Report 2, Agricultural 
Biotechnology: Food Safety and Nutritional Quality for the Consumer 
(1990) and NABC Report 17, Agricultural Biotechnology: Beyond Food 
and Energy to Health and the Environment (2005).
2 The proposal is relevant to the United States and Canada. Public agri­
cultural research institutions in both countries are members of NABC.
3 Centers for Disease Control and Prevention (2004). Chronic Disease 
Overview.
4 Links to additional information are available at NABC’s webpage 
http://nabc.cals.comell.edu/.
Vaccines
Vaccines are one of the most efficacious and economical 
methods ofpreventing disease and may also be used as therapy. 
Here, agricultural research was seminal. Cowpox provided 
the first human vaccine as cross-protection against small 
pox, which led to its eradication. In fact, the word vaccine, 
which was first used to describe the use of a cowpox-related 
vims, Vaccinia, to protect against smallpox, is derived from 
the Latin word for cow (vaccct). The FDA recently approved 
the first human vaccine against bird flu as a contingency 
against future outbreaks. Experimental vaccines produced 
by plants have been shown to lead to human immunity. 
Plant-produced vaccines have shown therapeutic potential 
for treating cancer; within mere weeks, tobacco plants 
genetically engineered with individual human-lymphoma 
antigens produced vaccines that were immunogenic.
Antibiotics
Agricultural research also provided the seminal advance 
for microbially-produced antibiotic therapy. Fleming 
discovered penicillin and showed that it was produced by a 
fungus commonly used in cheese making. However, it was 
not useful as a therapy until agricultural scientists selected 
fungal strains with higher productivity, and developed the 
fermentation system to produce clinically useful quantities 
for use in World War II. Other antibiotics are products of 
agricultural research.
Biosourced Therapeutics
Botanicals have been the source of over 25% of human 
therapeutic drugs. Aspirin for pain (and now cardiac- 
disease prevention) was originally isolated from willow 
bark; taxol for treating certain cancers was derived from 
the yew tree; the blood thinner coumadin was extracted 
from moldy sweet clover; and artemisinin from wormwood 
is a new cure for malaria, replacing quinine derived from 
cinchona bark. Therapeutics derived from animal sources 
include porcine insulin used to treat diabetes.
Chicken Dog, Pig & Plant Models
Chicken, dog, pig and, more recently, plant models have 
been useful in understanding and treating human diseases. 
Gene therapy to overcome retina-related blindness in dogs 
was a model for recent initial success in similar treatment 
of human blindness. Newborn pigs were used to understand 
how rotaviruses cause diarrhea and to develop oral 
vaccines against these devastating pathogens. Research 
using the model plant arabidopsis yielded discoveries 
with potential human-health benefits in the areas of, for 
example, inflammation and tumor suppression, macular 
degeneration, and arthritis.
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Production Systems
Chicken eggs are broadly used in human vaccine production 
partly because, while they support growth of mammalian 
pathogens, the product carries no risk of disease from the 
presence of avian pathogens. Agricultural research has led 
to the use of baculoviruses that infect insects as production 
systems for therapeutics and vaccines, e.g. HPV5 vaccine. 
These baculoviruses, grown using insect-cell lines, were 
initially developed to control insect infestations of crop 
plants.
HIV
Investigations of retroviruses in cats and chickens 
provided fundamental knowledge that jump-started 
understanding of HIV infection in the early 1980s.
Prion Diseases
Pioneering research on prion diseases like scrapie in sheep 
and mad-cow disease (bovine spongiform encephalopathy, 
BSE) in cattle provided the basis for understanding 
Creutzfeldt-Jakob disease (CJD) in humans.
Small-RNA Therapeutics & Diagnostics
Small RNAs control gene expression. Agricultural 
scientists made this seminal discovery by showing that 
they protect plants from viral infection. They are expected 
to have major impacts on cancer diagnosis and treatment, 
and treatments of cardiovascular and muscular diseases, 
diabetes, viral diseases, etc. A recent scientific article, 
"MicroRNAs make big impression in disease after 
disease,”6 captures the potential. A 2006 Nobel Prize was 
awarded for this area of research.
Biopharma Therapeutics & Xenotransplants
Agricultural and veterinary-medicine research produced 
the first transgenic plants and animals. Both transgenic 
plants and animals are being used, mainly experimentally, 
to biomanufacture therapeutics and vaccines—
“biopharma”—making it possible to rapidly scale up 
production of molecules that would otherwise be scarce or 
produced only by extraction from human tissues or blood. 
Absolute containment will be key so as to segregate pharma 
plants and animals from their food/feed counterparts. The 
Food and Drug Administration recently approved a plant- 
produced vaccine for animals and a human antithrombin 
produced in goat milk for humans with genetic deficiency. 
Bioengineered pigs may be a source of organs, such as 
livers, for xenotransplantation into humans.
5 Human papilloma vims.
6 Couzin, J. (2008) Science 319 1782-1784.
Other Landmark Contributions
Agriculture and veterinary medicine7 have been pioneers 
in innovations relating to disease. Examples include the 
discovery of the first mammalian virus, the agent of foot and 
mouth disease. Rous sarcoma was the first cancer shown 
to be caused by a virus. Marek's disease of chickens was 
the first cancer treated with a vaccine. HPV5 vaccine is now 
being broadly administered to women to reduce risk of 
cervical cancer. The first attenuated bacterium administered 
as a vaccine was for chicken cholera. Antibody-producing B- 
immune cells were discovered in bursa of chickens. Insect- 
transmitted diseases such as Texas fever contributed to the 
discovery that mosquitoes transmit malaria and yellow fever. 
Agricultural research developed DDT to stop transmission 
of insect-bome diseases. Male-sterile insects led to the 
eradication of the screwworm and its contamination of 
wounds, atechnology that has been used throughout the world. 
The emergence of the SARS coronavirus from an animal 
host and its pandemic spread in 2003, and recent concerns 
with bird flu and swine flu, illustrate the connection between 
diseases circulating in mammalian and avian populations and 
the potential problems they create by moving to humans.
Agricultural research related to human health has been 
recognized with over fifteen Nobel prizes, many relevant 
to human health. For example in the 1960s, the structure of 
transfer RNAs was elucidated, providing one of the keys of 
thegene-to-protein sequence in living organisms; to recognize 
this historic event, the US Department of Agriculture recently 
renamed the laboratory where the work was done the Robert 
W. Holley Center for Agriculture and Health.
Most of the above examples benefit human health 
through disease treatment, while some, such as 
vaccines, are also preventive. The following ex­
amples are mainly preventive. Some, such as 
essential vitamins, amino acids, fatty acids and 
micronutrients, have a history of preventive ben­
efits, but most of the others will require further 
research to realize such potential.
Essential Vitamins, Amino Acids, Fatty Acids & 
Micronutrients
Many earlier contributions of agricultural research were 
related to the discovery of essential vitamins, amino 
acids, minerals and fatty acids. For example, rickets was 
an important disease until the discovery that insufficient 
vitamin D is causal. Elucidation of this linkage, and the 
discovery in the 1920s that inclusion of irradiated milk in 
the diet could prevent the disease, resulted from agricultural
7 National Research Council (2005) Critical Needs for Research in Vet­
erinary Science. Washington, DC: The National Academies Press.
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research. Today, increasing the intake of vitamin D is being 
evaluated for prevention/treatment of certain cancers and 
cardiovascular disease. The role of omega-3 fatty acids, 
derived from fish, flax and nut foods, is being recognized in 
neural and cardiovascular health and in child development. 
Research is in progress to modify the fatty acid composition of 
plant lipids in order to improve the healthfulness of their oils, 
e.g. making soybean oil more like canola or olive oil. Plant 
proteins often do not have a distribution of amino acids that 
is optimal for the human diet. Com, with insufficient lysine, 
and soybean with too few sulfur-containing amino acids, are 
being modified to improve dietary balance. Vitamin A and 
its precursor |3-carotene are necessary for normal vision. In 
some developing countries where rice is a ma jor part of the 
diet, children become blind because of vitamin-A deficiency. 
Genetically improved generations of Golden Rice are being 
developed to contain enough |3-carotene to prevent millions 
of cases of blindness. The HarvestPlus Cassava Alliance, 
with Gates Foundation and other support, seeks to increase 
the P-carotene and iron and zinc contents (biofortification) of 
this major food crop for tropical America and Africa. Foods 
containing vitamins and other bioactives at levels much 
greater than minimal nutritional requirements are Functional 
Foods, which are expected to prevent or slow chronic disease 
development as nutrient levels have protected against acute 
nutritional diseases.
Functional Foods
Vitamins and other phytochemicals are suggested to have 
functions in disease prevention beyond their value as 
nutrients. Examples are antioxidants, phenolic acids and 
polyphenols (anthocyanins, proanthocyanidins, flavonones, 
isoflavones, resveratrol—associated with red wine—and 
ellagic acid). Lycopene, glucosinolates and allyl sulphides 
have been reported to have beneficial protective and/or 
therapeutic effects on a variety of diseases. Evidence for the 
effectiveness of these compounds is based mostly on cell and 
animal studies. Human clinical data are needed to establish 
efficacy, such as has been generated for the cholesterol- 
reducing effects of P-glucans in oats and barley.
Probiotics
Probiotics are microbes that promote health. Genome 
sequences of gut-flora bacteria are providing understanding 
of the molecular bases of health-promoting benefits. Dietary 
priobiotics are being marketed on the basis of promotion 
and maintenance of human health, e.g. as yoghurts with 
clinically proven gastrointestinal benefits.
Elimination/Reduction of Food-Borne Toxins
Plants contain toxins, their natural protectants against 
mammalian and pest predation. Some such toxins are 
highly poisonous to humans, e.g. ricin in castor beans.
Crops bioengineered for pest resistance have reduced 
levels of mold-produced aflatoxins. Some toxic compounds 
may cause chronic disease if consumed over long periods. 
Canadian researchers genetically modified oilseed rape, 
a mainly industrial crop, so as to reduce erucic acid and 
glucosinolates and produce canola, a major new food-oil 
source with desirable fatty acid composition. Elimination 
of plant toxins should make our foods more healthful, by 
reducing the diseases they cause.
Elimination/Reduction of Allergens
Many of our major foods—soybean, wheat, peanut, milk, 
eggs, shellfish, etc.—contain potent allergens that are 
i ntolerable or even lethal for some humans. Suscept i b i 1 i ty 
to these allergens is due to a combination of genetics, 
age, history and, potentially, the gut microbiota. Some 
of these foods, e.g. rice, wheat, soybean and peanut, 
are being genetically modified to eliminate/reduce their 
allergens.
Altering Diet
Altering the diet will mean inclusion of more healthful 
foods. Ideally, these foods will be similar to traditional 
counterparts, and, in some cases, will be enhanced in 
desirable flavors and tastes. Current technology enables 
modification of food composition, increasing desirable 
and decreasing undesirable components. Examples of 
modified foods already in the marketplace include milk 
that is reduced in fat content (2%, 1% and skim) and 
free of lactose for consumers who are lactose intolerant. 
Recent elimination of trans fatty acids in processed 
foods has improved their healthfulness. Wheat products 
reduced in gluten content may lower the incidence of 
celiac-disease symptoms. Organically produced food 
is another example; a small but growing number of 
consumers perceive increased healthfulness based on 
altered production methods and are willing to seek out and 
pay a premium for food that meets the organic standard. 
Although organic foods have notbeen proven scientifically 
to be more healthful, the broad expansion of organic food 
sections in grocery stores suggests ready acceptance of 
foods differentiated by verifiable changes in composition 
and clinical evidence of contributions to improved health. 
Some of these foods will be directed to niche markets 
of individuals based on their genetics. An encouraging 
2008 survey8 found that 67% of Americans have made 
changes to improve their diet; however, achieving broad 
improvement in the healthfulness of the national diet will 
need major initiatives in communication and education.
8 International Food Information Council (IFIC) (2008) 2008 Food & 
Health Survey: Consumer Attitudes Toward Food, Nutrition & Health. 
Washington, DC: IFIC.
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Enhancement of Flavor & Taste
The food pyramid was developed to guide consumers in 
selecting foods with cumulative beneficial effects, e.g. those 
with less sugar and fat, and more fruits and vegetables. 
Considering the increasing rates of obesity, diabetes and 
other chronic diseases, less-healthy foods are winning the 
acceptance race versus more healthy foods. A major factor 
in this unfavourable situation is the dominant role of taste— 
less-healthy foods often have preferred taste. Taste and price 
have the greatest impacts on food-purchase decisions8.
Improving taste and flavor should enhance acceptance 
and consumption of healthy foods. Different individuals 
detect flavors differently, based on their genes. For 
example, about 20% of the population do not like the taste 
of broccoli, which is recognized to provide human-health 
benefits. Human taste buds detect at least five tastes: sweet, 
salty, bitter, sour and umami (savory). Researchers are 
using receptors for the various tastes to develop GRAS9 
compounds, as alternatives or enhancers, to reduce intake 
of sugar, fat, salt, etc. These molecular approaches should 
provide powerful redirection of food selection with the 
potential to increase the consumption of healthier foods 
with protective benefits.
Genetic Modification
Many of the benefits described above will require genetic 
modification of the food source. Some will require 
"traditional'’ breeding as has been done overthe years to most 
of our plant, animal and microbial food sources. For example, 
the conversion of rapeseed to canola used traditional plant 
breeding at the organismal level to produce the desired 
genetic modification. On the other hand, molecular genetic 
techniques were used to engineer microbial production of 
highly pure—98%—chymosin for manufacture of hard 
cheeses. The bioengineered product, FDA-approved in the 
early 1990s, has largely replaced crude chymosin (rennin, 
only 2% pure) obtained from calf stomachs. Crop plants, 
such as soybean and com, genetically engineered with 
improved agronomic traits, are being commercialized in 
most of the world except Europe. Most of the soybean grown 
worldwide is bioengineered. For many of the projected 
health benefits, food crops and possibly animals will need to 
be modified using molecular genetics as well as traditional 
methods. Research investment is needed to develop the 
scientific base to evaluate these products and, in due course, 
to assure domestic and export markets that they are safe for 
consumption. These products must be as safe as their non- 
engineered parents; in addition, they will provide health 
benefits beyond those of their parents.
Nutrigenomics
Developments in biology and genomics will provide 
the opportunity to couple agriculture, food and nutrition
9 Generally regarded as safe.
with new approaches to improving human health 
(nutrigenomics10). A few individual human genomes 
have already been sequenced and major efforts are being 
focused on developing low-cost genomic sequencing 
for individuals. The information generated by these 
approaches will provide the bases for clinical trials that 
can link individual genotypes to outcomes, in contrast 
to the current "one size fits all” approach. In addition 
to genomics, an expanded use of other "omics,” such 
as metabolomics, will provide more precise diagnostic 
and treatment directions. These innovations will lead 
to a greater ability to design prevention-and-treatment 
interventions that depend on implementing diet and life­
style changes, initially at the group level and, in time, may 
be individualized.
Food Safety
Food safety, essential to human health, will be 
further improved by continued innovation. Microbial 
contamination of fruit and vegetable produce and animal 
and poultry products is the major cause of food poisoning. 
Improved diagnostics and traceability will reduce 
microbial-contamination problems. Irradiation is another 
option to minimize food-bome illnesses. Production 
practices, such as routine use of antibiotics in poultry 
and animal production, are being discontinued so as to 
diminish development of antibiotic resistance in microbes 
infecting humans, and to prolong efficacy of antibiotics. 
Animal vaccines were recently introduced to reduce 
shedding of toxic microbes during meat processing. 
Rapid-readout online tests of poultry, animal and vegetable 
products should identify unsafe foods before they enter the 
distribution chain. In addition, country-of-origin labelling 
will facilitate traceability.
Communication & Education
Disseminating the message of the necessity to eat more 
healthfully will need massive and continuous efforts in 
our educational institutions, but also aimed at adults. The 
potential benefits are compelling: improved longevity 
and quality of life, reduced chronic-disease rates and 
containment of national healthcare expenditures. Major 
reduction in smoking over the past 50 years provides a 
good analogy. Newsletters dealing with human nutrition are 
available from university and advocacy organizations—one 
of which has about a million subscribers11—documenting 
the interest in diet and health. A rating system using stars 
to identify the nutritional value of supermarket foods has 
been introduced and should facilitate consumer selection 
of healthy food.
10 The National Academies Food and Nutrition Board (2007) Nutrige- 
nomics and Beyond: Informing the Future—Workshop Summary. Wash­
ington DC: The National Academies Press.
11 Nutrition Action Newsletter, published by the Center for Science in 
the Public Interest.
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Action Plan
The following action plan is proposed for expeditious delivery of the benefits outlined above, to reduce the 
cost of healthcare and improve the quality of life.
• Research in food and agriculture, including nutrition 
and veterinary medicine, must become a full partner in 
the national mission to improve health. Our academic 
and government structures separate food and agriculture 
and human health. Colleges of agriculture and life 
sciences function separately from colleges of medicine 
and public health; the US Department of Agriculture 
is separate from the Department of Health and Human 
Services; governmental appropriations for agriculture 
are separate from those for human health. The proposed 
One Health Initiative is an encouraging step, seeking 
to unite veterinary and human medicine. Expansion is 
needed to unite food and agricultural research with health 
in both academe and government.
• Public funding for food and agricultural research, including 
nutrition and veterinary medicine, requires a log step 
increase, not redirection of existing funding, to provide 
the knowledge and technology for the disease-prevention 
opportunities outlined. The National Institute of Food 
and Agriculture (NIFA) initiative could be a canopy. The 
new USDA Agriculture and Food Research Initiative 
(AFRI) is a positive step; however, a much larger funding 
commitment is needed.
• Funding should be competitive and open to individuals, 
to generate new knowledge, and, in particular, to self-
assembledgroupsfrom food, agriculture andhealthfocussed 
on specific targets and possessing the necessary breadth of 
skills, e.g. scientists, economists, sociologists, clinicians, 
marketers, regulators and communicators/educators from 
academe, government and industry. Examples exist of 
such integrated programs in food, agriculture and human 
health12. Inclusion of academe, government and industry 
seeks to capture outstanding talent independent of sector 
location and, in the case of industry, couples the technology 
to its ultimate delivery.
• The targeted programs may include functional foods, 
probiotics, reduction/elimination of food-bome toxins, 
reduction/elimination of allergens, diet alteration, flavor 
and taste enhancement, nutrigenomics, food safety, 
communication/education, and others to be identified.
• An initial long-term commitment (e.g. 5 years) will be 
needed to attract the innovative individuals needed to assure 
the desired outcomes in these challenging programs.
In conclusion, food and agricultural research has an 
outstanding record of contributions to human health, many 
seminal, and this action plan should expand the established 
record and. in addition, provide important low-cost prevention 
of diet-based chronic diseases.
12 Integrated food, agriculture and human health programs include the 
North Carolina Research Campus, the Linus Pauling Institute at Oregon 
State University, the functional foods component of the Agricultural 
Bioproducts Innovation Program at Agriculture and Agri-Food Canada, 
and the USDA’s Human Research Centers, one of which is at a college 
of medicine.
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